Data for ST002214
Metabolite structure | All data | F1 | F2 | F3 | F4 | F5 |
---|---|---|---|---|---|---|
2^,3^-Cyclic CMP | 13407.16 | 22299.30 | 3296.34 | 17934.88 | 30634.07 | |
2/3-Phospho-D-glycerate | 122305.61 | 114850.79 | 5364.54 | 100034.87 | 279533.10 | |
2-Oxoglutaramate | 14283.81 | 18451.81 | 39660.96 | 16443.08 | 17176.40 | |
3-Phosphonooxypyruvate | 4349.07 | 5049.92 | 7540.98 | 4665.78 | 4661.53 | |
(7Z-10Z-13Z-16Z-19Z)-Docosa-7-10-13-16-19-pentaenoic acid | 6560.31 | 9125.18 | 127746.05 | 3231.61 | 18317.23 | |
(8Z-11Z-14Z)-Icosatrienoic acid | 13177.24 | 11786.21 | 139187.88 | 6780.70 | 30354.67 | |
alpha-D-Ribose 1-phosphate | 660046.78 | 534849.78 | 94543.36 | 676127.27 | 798992.80 | |
Ascorbate | 36493.61 | 26981.86 | 79776.87 | 36252.80 | 21948.09 | |
Citrate | 1192549.60 | 921907.35 | 894796.35 | 1093280.87 | 1060079.33 | |
dAMP | 7898.09 | 12314.92 | 6731.83 | 8626.29 | 14460.03 | |
dCMP | 15824.37 | 21643.59 | 6288.35 | 18355.82 | 29849.55 | |
Decanoic acid (caprate) | 394633.33 | 432737.50 | 575040.15 | 445225.13 | 410681.43 | |
D-Glucose | 372125.88 | 421466.85 | 77858.84 | 344359.60 | 481616.73 | |
D-Glyceraldehyde 3-phosphate/Glycerone phosphate | 122305.61 | 114850.79 | 5364.54 | 100034.87 | 279533.10 | |
Dimethylglycine | 12736.39 | 15019.77 | 1604.01 | 17043.95 | 39735.53 | |
Diphosphate | 7791543.25 | 7640562.00 | 26090005.00 | 8354705.00 | 12894306.67 | |
Docosahexaenoic acid | 4777.26 | 4164.11 | 81695.56 | 2156.99 | 15957.11 | |
Dodecanoic acid | 397789.58 | 661595.57 | 911148.00 | 391686.43 | 501829.70 | |
Eicosapentaenoic acid | 4299.69 | 2690.24 | 49226.91 | 3190.77 | 18506.06 | |
Eicosatetraenoic acid | 14057.02 | 6109.46 | 169537.87 | 5711.68 | 29437.74 | |
Fumarate | 30884.93 | 35885.02 | 10596.97 | 23697.29 | 27703.15 | |
Hexadecanoic acid | 6924485.75 | 5793353.00 | 26165550.00 | 5429475.33 | 7354544.33 | |
Lactate | 3207787.75 | 3235249.50 | 1264303.55 | 3866100.67 | 2086439.00 | |
L-gamma-Glutamyl-L-hypoglycin | 13746.02 | 14370.20 | 10234.78 | 19352.88 | 31276.71 | |
Linoleate | 97566.99 | 70420.67 | 726747.90 | 64048.13 | 253802.97 | |
L-Selenomethionine | 44574.05 | 50527.58 | 50943.18 | 46363.38 | 67134.16 | |
Malate | 609627.25 | 526057.45 | 369658.65 | 474512.53 | 563055.67 | |
Maltose | 32881.14 | 102070.63 | 26355.88 | 42957.28 | 22396.31 | |
Maltotriose | 30781.99 | 13419.45 | 15878.56 | 13222.46 | 13655.38 | |
Mannitol | 103021.59 | 89750.87 | 54184.79 | 70374.74 | 73580.46 | |
N-Acetyl-L-citrulline | 26882.99 | 35785.58 | 9999.89 | 36271.24 | 45856.53 | |
N-Acetylneuraminate | 16405.68 | 17902.35 | - | 26368.58 | 28062.77 | |
N-Acetylornithine | 29375.77 | 36558.07 | 7246.36 | 46886.49 | 78518.60 | |
Nonanoic acid (pelargonate) | 980892.82 | 987964.90 | 1423512.50 | 1023935.60 | 967008.57 | |
Octadecanoic acid | 4286527.00 | 3867226.00 | 14881680.00 | 3591354.33 | 4147229.00 | |
Octadecatrienoic acid | 18512.34 | 13658.94 | 131759.43 | 12434.09 | 57544.02 | |
Octadecenoic acid | 235813.12 | 205432.00 | 1532687.75 | 195175.53 | 403069.20 | |
Oxaloacetate | 48279.07 | 39913.73 | 58417.43 | 40454.39 | 44215.08 | |
Pantetheine | 13868.38 | 18913.03 | 2512.04 | 17632.53 | 30374.43 | |
Phosphate | 70044517.50 | 68878830.00 | 196420700.00 | 70653750.00 | 105937866.67 | |
Phosphoenolpyruvate | 19676.53 | 17730.18 | 2067.09 | 15401.45 | 55433.11 | |
Sedoheptulose 1-phosphate | 28033.01 | 30979.83 | - | 68409.70 | 104313.13 | |
Succinate | 360427.17 | 282927.28 | 303977.40 | 249654.80 | 300049.77 | |
Tetradecanoic acid | 605412.95 | 555368.05 | 2493507.50 | 530536.80 | 618974.60 | |
Tetradecenoic acid | 24718.78 | 48308.18 | 59392.99 | 22996.78 | 29898.71 | |
UDP-glucose | 8429.37 | 12177.49 | - | 8339.17 | 14872.68 | |
UDP-N-acetyl-D-glucosamine | 35079.83 | 46660.88 | - | 39251.27 | 96189.14 |
Factors:
F1 | Condition:Alzheimer patient | Treatment:DMSO |
F2 | Condition:Alzheimer patient | Treatment:Shikonin |
F3 | Condition:non-demented control | Treatment:CoDo Treatment |
F4 | Condition:non-demented control | Treatment:GFP-overexpression |
F5 | Condition:non-demented control | Treatment:PKM2-overexpression |